123 related articles for article (PubMed ID: 1640711)
1. Primary oesophageal carcinoma in teens.
Kumar A; Shukla NK; Mishra MC; Shahi UP; Kapur BM
J Surg Oncol; 1992 Aug; 50(4):254-7. PubMed ID: 1640711
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
Davies L; Lewis WG; Arnold DT; Escofet X; Blackshaw G; Gwynne S; Evans M; Roberts SA; Appadurai I; Crosby TD
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
[TBL] [Abstract][Full Text] [Related]
4. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
5. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998.
Wilson KS; Wilson AG; Dewar GJ
Can J Gastroenterol; 2002 Jun; 16(6):361-8. PubMed ID: 12096299
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies for esophageal cancer.
Nieman DR; Peters JH
Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
[TBL] [Abstract][Full Text] [Related]
7. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
[TBL] [Abstract][Full Text] [Related]
9. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
[TBL] [Abstract][Full Text] [Related]
10. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
[TBL] [Abstract][Full Text] [Related]
11. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
12. A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92.
Becerra CR; Hanna N; McCollum AD; Becharm N; Timmerman RD; DiMaio M; Kesler KA; Yu M; Yan T; Choy H
J Thorac Oncol; 2013 Nov; 8(11):1425-9. PubMed ID: 24084441
[TBL] [Abstract][Full Text] [Related]
13. Combined modality therapy in esophageal cancer.
Einhorn LH
J Clin Oncol; 1990 Jul; 8(7):1286-7. PubMed ID: 2358843
[No Abstract] [Full Text] [Related]
14. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
González Ortiz DI; Toro DH
Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
[TBL] [Abstract][Full Text] [Related]
15. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
[No Abstract] [Full Text] [Related]
16. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.
Robb WB; Messager M; Dahan L; Mornex F; Maillard E; D'Journo XB; Triboulet JP; Bedenne L; Seitz JF; Mariette C; ; ; ; ;
Br J Surg; 2016 Jan; 103(1):117-25. PubMed ID: 26511668
[TBL] [Abstract][Full Text] [Related]
17. Synchronous triple primary cancers of the pharynx and esophagus.
Kataoka S; Omae M; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada K; Igarashi M
Clin J Gastroenterol; 2017 Jun; 10(3):208-213. PubMed ID: 28315155
[TBL] [Abstract][Full Text] [Related]
18. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?
Chan A; Wong A
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):265-70. PubMed ID: 10487544
[TBL] [Abstract][Full Text] [Related]
19. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
20. Oesophageal cancer.
Lagergren J; Smyth E; Cunningham D; Lagergren P
Lancet; 2017 Nov; 390(10110):2383-2396. PubMed ID: 28648400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
